
Cefoat S 250mg/125mg Injection
Marketer
Zota Health care Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefoat S 250mg/125mg Injection
Cefoat S 250mg/125mg injectable solution is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be overseen by a medical professional; adhere strictly to the prescribed dosage schedule. Complete the full course of treatment, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified reactions necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Disclose all current medications to your physician before commencing treatment, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from operating vehicles if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and ample hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor treatment effectiveness.
Uses of Cefoat S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefoat S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefoat S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefoat S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cefoat S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefoat S 250 mg/125 mg Injection, offer a dual-action approach to bacterial infections. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Cefoat S 250 mg/125 mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Cefoat S 250 mg/125 mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Cefoat S 250 mg/125 mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefoat S 250 mg/125 mg Injection might cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Cefoat S 250 mg/125 mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Cefoat S 250 mg/125 mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefoat S 250 mg/125 mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefoat S 250mg/125mg Injection :
Omit a Cefoat S 250 mg/125 mg Injection dose? Seek medical advice immediately.
Facts to Know About Cefoat S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
